Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1973 Nov;4(5):525–531. doi: 10.1128/aac.4.5.525

Clinical Studies of Cefazolin and Comparison with Other Cephalosporins

T Madhavan 1,2, Edward L Quinn 1,2, Earl Freimer 1,2, Evelyn J Fisher 1,2, Frank Cox 1,2, Keith Burch 1,2, Donald Pohlod 1,2
PMCID: PMC444589  PMID: 4791486

Abstract

Cefazolin, a new cephalosporin derivative, was studied in the treatment of 105 hospitalized patients with a variety of infections including endocarditis, pneumonia, and urinary and soft tissue infections, and was found to be effective in 104 patients. Cefazolin was also tested in vitro and shown to be effective against staphylococci, pneumococci, Escherichia coli, Klebsiella sp., and Proteus mirabilis by agar dilution method. It was shown to produce high serum levels when administered in a 250- to 1,000-mg intramuscular dose and was well tolerated and free from renal toxicity. Comparison of the results of this study with those from our prior studies on cephaloridine revealed equivalent antibiotic potency, good tolerance to both the agents when given intramuscularly, superior, average blood levels with cefazolin, equal clinical efficacy, and absence of renal toxicity with cefazolin (unlike cephaloridine). Similarly, the results of treatment of pneumococcal pneumonia with intramuscular cefazolin were found to be superior to those for oral cephalexin.

Full text

PDF
525

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cox F., Jr, Quinn E. L., Gatmaitan B. G., Peterson N. Cephalexin. In vitro and in vivo studies. Henry Ford Hosp Med J. 1970 Summer;18(2):91–98. [PubMed] [Google Scholar]
  2. Fleming P. C., Jaffe D. The nephrotoxic effect of cephaloridine. Postgrad Med J. 1967 Aug;43(Suppl):89–90. [PubMed] [Google Scholar]
  3. Fujii R. Clinical and laboratory evaluation of cephaloridine in infants and children. Postgrad Med J. 1967 Aug;43(Suppl):151–154. [PubMed] [Google Scholar]
  4. GRIFFITH R. S., BLACK H. R. CEPHALOTHIN--A NEW ANTIBIOTIC. PRELIMINARY CLINICAL AND LABORATORY STUDIES. JAMA. 1964 Sep 14;189:823–828. [PubMed] [Google Scholar]
  5. Gralnick H. R., Wright L. D., Jr, McGinniss M. H. Coombs' positive reactions associated with sodium cephalothin therapy. JAMA. 1967 Mar 6;199(10):725–726. [PubMed] [Google Scholar]
  6. HERRELL W. E., BALOWS A., BECKER J. SOME EXPERIMENTAL AND CLINICAL STUDIES ON CEPHALOTHIN. Clin Pharmacol Ther. 1963 Nov-Dec;4:709–719. doi: 10.1002/cpt196346709. [DOI] [PubMed] [Google Scholar]
  7. Johnson W. D., Applestein J. M., Kaye D. Cephaloglycin. Clinical and laboratory experience with an orally administered cephalosporin. JAMA. 1968 Dec 16;206(12):2698–2702. doi: 10.1001/jama.206.12.2698. [DOI] [PubMed] [Google Scholar]
  8. KLEIN J. O., EICKHOFF T. C., TILLES J. G., FINLAND M. CEPHALOTHIN: ACTIVITY IN VITRO, ABSORPTION AND EXCRETION IN NORMAL SUBJECTS AND CLINICAL OBSERVATIONS IN 40 PATIENTS. Am J Med Sci. 1964 Dec;248:640–656. [PubMed] [Google Scholar]
  9. Kaplan K., Reisberg B., Weinstein L. Cephaloridine. Studies of therapeutic activity and untoward effects. Arch Intern Med. 1968 Jan;121(1):17–23. doi: 10.1001/archinte.121.1.17. [DOI] [PubMed] [Google Scholar]
  10. Kind A. C., Kestle D. G., Standiford H. C., Kirby W. M. Laboratory and clinical experience with cephalexin. Antimicrob Agents Chemother (Bethesda) 1968;8:361–365. [PubMed] [Google Scholar]
  11. Lane R. A., Cox F., McHenry M., Quinn E. L. Cephaloridine, laboratory and clinical evaluation. Antimicrob Agents Chemother (Bethesda) 1966;6:88–95. [PubMed] [Google Scholar]
  12. Levison M. E., Johnson W. D., Thornhill T. S., Kaye D. Clinical and in vitro evaluation of cephalexin. A new orally administered cephalosporin antibiotic. JAMA. 1969 Sep 1;209(9):1331–1336. [PubMed] [Google Scholar]
  13. Linsell W. D., Pines A., Hayden J. W. Abnormal urinary deposits in cephaloridine therapy. Postgrad Med J. 1967 Aug;43(Suppl):90–92. [PubMed] [Google Scholar]
  14. MURDOCH J. M., SPEIRS C. F., GEDDES A. M., WALLACE E. T. CLINICAL TRIAL OF CEPHALORIDINE (CEPORIN), A NEW BROAD-SPECTRUM ANTIBIOTIC DERIVED FROM CEPHALOSPORIN C. Br Med J. 1964 Nov 14;2(5419):1238–1240. doi: 10.1136/bmj.2.5419.1238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Molthan L., Reidenberg M. M., Eichman M. F. Positive direct Coombs tests due to cephalothin. N Engl J Med. 1967 Jul 20;277(3):123–125. doi: 10.1056/NEJM196707202770303. [DOI] [PubMed] [Google Scholar]
  16. Nishida M., Matsubara T., Murakawa T., Mine Y., Yokota Y. Cefazolin, a new semisynthetic cephalosporin antibiotic. II. In vitro and in vivo antimicrobial activity. J Antibiot (Tokyo) 1970 Mar;23(3):137–148. doi: 10.7164/antibiotics.23.137. [DOI] [PubMed] [Google Scholar]
  17. Nishida M., Matsubara T., Murakawa T., Mine Y., Yokota Y., Kuwahara S., Goto S. In vitro and in vivo evaluation of cefazolin, a new cephalosporin C derivative. Antimicrob Agents Chemother (Bethesda) 1969;9:236–243. [PubMed] [Google Scholar]
  18. Reller L. B., Karney W. W., Beaty H. N., Holmes K. K., Turck M. Evaluation of cefazolin, a new cephalosporin antibiotic. Antimicrob Agents Chemother. 1973 Apr;3(4):488–497. doi: 10.1128/aac.3.4.488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ries K., Levison M. E., Kaye D. Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic. Antimicrob Agents Chemother. 1973 Feb;3(2):168–174. doi: 10.1128/aac.3.2.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ruedy J. A clinical trial of cephaloridine. Can Med Assoc J. 1966 Jun 25;94(26):1343–1348. [PMC free article] [PubMed] [Google Scholar]
  21. Shibata K., Fujii M. Clinical studies of cefazolin in the surgical field. Antimicrob Agents Chemother (Bethesda) 1970;10:467–472. doi: 10.1128/AAC.10.3.467. [DOI] [PubMed] [Google Scholar]
  22. Stewart G. T. Hypersensitivity and toxicity of the beta-lactam antibiotics. Postgrad Med J. 1967 Aug;43(Suppl):31–36. [PubMed] [Google Scholar]
  23. Thornton G. F., Andriole V. T. Laboratory and clinical studies of a new antibiotic, cephaloridine, in the treatment of gram-positive infections. Yale J Biol Med. 1966 Aug;39(1):9–20. [PMC free article] [PubMed] [Google Scholar]
  24. Turck M., Belcher D. W., Ronald A., Smith R. H., Wallace J. F. New cephalosporin antibiotic--cephaloridine. Clinical and laboratory evaluation. Arch Intern Med. 1967 Jan;119(1):50–59. doi: 10.1001/archinte.119.1.50. [DOI] [PubMed] [Google Scholar]
  25. WALTERS E. W., ROMANSKY M. J., JOHNSON A. C. CEPHALOTHIN--LABORATORY AND CLINICAL STUDIES IN 109 PATIENTS. Antimicrob Agents Chemother (Bethesda) 1963;161:247–253. [PubMed] [Google Scholar]
  26. WEINSTEIN L., KAPLAN K., CHANG T. W. TREATMENT OF INFECTIONS IN MAN WITH CEPHALOTHIN. JAMA. 1964 Sep 14;189:829–834. doi: 10.1001/jama.1964.03070110031006. [DOI] [PubMed] [Google Scholar]
  27. Weinstein L., Kaplan K. The cephalosporins. Microbiological, chemical, and pharmacological properties and use in chemotherapy of infection. Ann Intern Med. 1970 May;72(5):729–739. doi: 10.7326/0003-4819-72-5-729. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES